Long-Term Wegovy Safety and Effectiveness Monitored in Real-World Obesity Study in Japan
Special Use - Results Surveillance on Long-term Use With Wegovy®
Abstract
A Multi-centre, Prospective, Non-interventional, Single-armed, 104 Weeks Post-marketing Study to Investigate Safety and Clinical Parameters of Wegovy® Once Weekly in Patients With Obesity Disease Under Real-world Clinical Practice Condition…
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
